Replimune price target raised to $22 from $21 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Replimune (REPL) to $22 from $21 and keeps a Buy rating on the shares. The firm expects a ...
stockstelegraph23m
Michael Cherny
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities ...